Skip to main content
Erschienen in: Neurological Sciences 2/2024

25.08.2023 | Original Article

Quality control in treating patients with patent foramen ovale: 7-year-experience of the Heart and Brain team of the Careggi University Hospital

verfasst von: Francesco Meucci, Costanza Maria Rapillo, Miroslava Stolcova, Giulia Domna Scrima, Giulia Nardi, Rita Nistri, Francesca Ristalli, Nicoletta D’Ettore, Alessio Mattesini, Francesco Buonamici, Benedetta Piccardi, Laura Tudisco, Antonella Cramaro, Sara Trapani, Giovanni Pracucci, Patrizia Nencini, Carlo Di Mario, Cristina Sarti

Erschienen in: Neurological Sciences | Ausgabe 2/2024

Einloggen, um Zugang zu erhalten

Abstract

Background

The right comprehension of ischemic stroke pathogenesis guarantees the best prevention therapy. The term “patent foramen ovale (PFO) related stroke” has been proposed for those events where PFO is supposed to be pathogenetic, but their definition is challenging. A multidisciplinary evaluation in a "Heart & Brain" team (HBteam) including stroke neurologists and interventional cardiologists was therefore highly recommended in the recent guidelines of secondary stroke prevention.

Objective

We aimed at describing the organization of the HBteam of Careggi-University-Hospital of Florence (Italy), and the results of the first seven years of activity.

Methods

In 2016 Interventional Cardiologists and Stroke Neurologists set up an outpatient clinic for the joined evaluation of patients with PFO and other cardio/neurological conditions. A specific diagnostic-therapeutic hospital plan was produced for PFO patients. Patient empowerment was guaranteed by a hospital explicative webpage, a booklet regarding risks/benefits of PFO closure and a 3D heartmodel to simulate the intervention. Data were collected in a dedicated registry.

Results

We evaluated 594 patients for PFO, 40 for left atrial appendage closure and 38 for other conditions. In 20% of PFO-patients, HBteam diagnosis was discordant from that of referring physicians, 14% were stroke misdiagnoses. We advised against closure in 53% of patients. At follow-up 94% of closed patients had no/minimum residual shunt; 3 patients had a cerebral ischemic event.

Conclusions

A dedicated HBteam represents a unique opportunity to share decisions with patients after a thorough empowerment process. The joining of cardioneurological skills allows a better classification of PFO-patients, reducing futile interventions.
Literatur
1.
Zurück zum Zitat Quenardelle V, Lauer-Ober V, Zinchenko I, Bataillard M, Rouyer O, Beaujeux R et al (2016) Stroke mimics in a stroke care pathway based on MRI screening. Cerebrovasc Dis 42:205–212CrossRefPubMed Quenardelle V, Lauer-Ober V, Zinchenko I, Bataillard M, Rouyer O, Beaujeux R et al (2016) Stroke mimics in a stroke care pathway based on MRI screening. Cerebrovasc Dis 42:205–212CrossRefPubMed
3.
Zurück zum Zitat Edlow JA, Selim MH et al (2011) Atypical presentations of acute cerebrovascular syndromes. Lancet Neurol 10(6):550–560 Edlow JA, Selim MH et al (2011) Atypical presentations of acute cerebrovascular syndromes. Lancet Neurol 10(6):550–560
4.
Zurück zum Zitat Richoz B, Richoz B, Hugli O, Dami F, Carron PN, Faouzi M, Michel P (2015) Acute stroke chameleons in a university hospital. Neurology 85:505–511CrossRefPubMed Richoz B, Richoz B, Hugli O, Dami F, Carron PN, Faouzi M, Michel P (2015) Acute stroke chameleons in a university hospital. Neurology 85:505–511CrossRefPubMed
5.
Zurück zum Zitat Dupre CM, Libman R, Dupre SI, Katz JM, Rybinnik I, Kwiatkowski T (2014) Stroke Chameleons. J Stroke Cerebrovasc Dis 23(2):374–378CrossRefPubMed Dupre CM, Libman R, Dupre SI, Katz JM, Rybinnik I, Kwiatkowski T (2014) Stroke Chameleons. J Stroke Cerebrovasc Dis 23(2):374–378CrossRefPubMed
6.
Zurück zum Zitat Meissner I, Khandheria BK, Heit JA, Petty GW, Sheps SG, Schwartz GL et al (2006) Patent foramen ovale: innocent or guilty? Evidence from a prospective population-based study. J Am Coll Cardiol 47:440–445CrossRefPubMed Meissner I, Khandheria BK, Heit JA, Petty GW, Sheps SG, Schwartz GL et al (2006) Patent foramen ovale: innocent or guilty? Evidence from a prospective population-based study. J Am Coll Cardiol 47:440–445CrossRefPubMed
7.
Zurück zum Zitat Di Tullio MR, Sacco RL, Sciacca RR, Jin Z, Homma S (2007) Patent foramen ovale and the risk of ischemic stroke in a multiethnic population. J Am Coll Cardiol 49:797–802CrossRefPubMed Di Tullio MR, Sacco RL, Sciacca RR, Jin Z, Homma S (2007) Patent foramen ovale and the risk of ischemic stroke in a multiethnic population. J Am Coll Cardiol 49:797–802CrossRefPubMed
8.
Zurück zum Zitat Mas J, Derumeaux G, Guillon B, Massardier E, Hosseini H, Mechtouff L et al (2017) Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke. CLOSE. N Engl J Med 377:1011–21CrossRefPubMed Mas J, Derumeaux G, Guillon B, Massardier E, Hosseini H, Mechtouff L et al (2017) Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke. CLOSE. N Engl J Med 377:1011–21CrossRefPubMed
9.
Zurück zum Zitat Saver J, Carroll J, Thaler D, Smalling R, MacDonald L, Marks D et al (2017) Long-term outcomes of patent foramen ovale closure or medical therapy after stroke. RESPECT N Engl J Med 377:1022–1032CrossRefPubMed Saver J, Carroll J, Thaler D, Smalling R, MacDonald L, Marks D et al (2017) Long-term outcomes of patent foramen ovale closure or medical therapy after stroke. RESPECT N Engl J Med 377:1022–1032CrossRefPubMed
10.
Zurück zum Zitat Søndergaard L, Kasner S, Rhodes J, Andersen G, Iversen H, Nielsen-Kudsk J et al (2017) Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke. REDUCE N Engl J Med 377:1033–1042CrossRefPubMed Søndergaard L, Kasner S, Rhodes J, Andersen G, Iversen H, Nielsen-Kudsk J et al (2017) Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke. REDUCE N Engl J Med 377:1033–1042CrossRefPubMed
11.
Zurück zum Zitat Lee P, Song J, Kim J, Heo R, Lee S, Kim D et al (2018) Cryptogenic stroke and high-risk patent foramen ovale: the DEFENSE-PFO trial. J Am Coll Cardiol 71(20) Lee P, Song J, Kim J, Heo R, Lee S, Kim D et al (2018) Cryptogenic stroke and high-risk patent foramen ovale: the DEFENSE-PFO trial. J Am Coll Cardiol 71(20)
12.
Zurück zum Zitat Kleindorfer D, Towfighi A, Chaturvedi S, Cockroft K, Gutierrez J, Lombardi-Hill D et al (2021) Guideline for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke 52:e364–e467PubMed Kleindorfer D, Towfighi A, Chaturvedi S, Cockroft K, Gutierrez J, Lombardi-Hill D et al (2021) Guideline for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke 52:e364–e467PubMed
13.
Zurück zum Zitat Pristipino C, Sievert H, D’Ascenzo F, Mas JL, Meier B, Scacciatella P et al (2018) European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism. Eur Heart J 00:1–14 Pristipino C, Sievert H, D’Ascenzo F, Mas JL, Meier B, Scacciatella P et al (2018) European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism. Eur Heart J 00:1–14
14.
Zurück zum Zitat Alkhouli M, Graff-Radford J, Holmes D (2018) The Heart-Brain Team - towards an optimal team-based coordinated care. JAMA Cardiol. Published online January 17, 2018 Alkhouli M, Graff-Radford J, Holmes D (2018) The Heart-Brain Team - towards an optimal team-based coordinated care. JAMA Cardiol. Published online January 17, 2018
16.
Zurück zum Zitat Kim JS, Thijs V, Yudi M, Toyoda K, Shiozawa M, Zening J et al (2022) Establishment of the Heart and Brain Team for patent foramen ovale closure in stroke patients: an expert opinion. J Stroke 24:345–351CrossRefPubMedPubMedCentral Kim JS, Thijs V, Yudi M, Toyoda K, Shiozawa M, Zening J et al (2022) Establishment of the Heart and Brain Team for patent foramen ovale closure in stroke patients: an expert opinion. J Stroke 24:345–351CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Sarti C, Stolcova M, Scrima G, Mori F, Failli Y, Accavone D et al (2020) Atrial fibrillation and resistant stroke: does left atrial appendage morphology matter? A case report. Front Neurol 11:592458CrossRefPubMedPubMedCentral Sarti C, Stolcova M, Scrima G, Mori F, Failli Y, Accavone D et al (2020) Atrial fibrillation and resistant stroke: does left atrial appendage morphology matter? A case report. Front Neurol 11:592458CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Turc G, Lee J, Brochet E, Kim J, Song J-K, Mas J et al (2020) Atrial septal aneurysm, shunt size, and recurrent stroke risk in patients with patent foramen ovale. J Am Coll Cardiol 75(18):2312–2320CrossRefPubMed Turc G, Lee J, Brochet E, Kim J, Song J-K, Mas J et al (2020) Atrial septal aneurysm, shunt size, and recurrent stroke risk in patients with patent foramen ovale. J Am Coll Cardiol 75(18):2312–2320CrossRefPubMed
19.
Zurück zum Zitat Kent D, Ruthazer R, Weimar C, Mas JL, Serena J, Homma S et al (2013) An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke. Neurology 81:619–625CrossRefPubMedPubMedCentral Kent D, Ruthazer R, Weimar C, Mas JL, Serena J, Homma S et al (2013) An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke. Neurology 81:619–625CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Kent D, Saver J, Ruthazer R, Furlan A, Reisman M, Carroll J et al (2020) Risk of paradoxical embolism (RoPE)–estimated attributable fraction correlates with the benefit of patent foramen ovale closure. Stroke 51:3119–3123CrossRefPubMedPubMedCentral Kent D, Saver J, Ruthazer R, Furlan A, Reisman M, Carroll J et al (2020) Risk of paradoxical embolism (RoPE)–estimated attributable fraction correlates with the benefit of patent foramen ovale closure. Stroke 51:3119–3123CrossRefPubMedPubMedCentral
Metadaten
Titel
Quality control in treating patients with patent foramen ovale: 7-year-experience of the Heart and Brain team of the Careggi University Hospital
verfasst von
Francesco Meucci
Costanza Maria Rapillo
Miroslava Stolcova
Giulia Domna Scrima
Giulia Nardi
Rita Nistri
Francesca Ristalli
Nicoletta D’Ettore
Alessio Mattesini
Francesco Buonamici
Benedetta Piccardi
Laura Tudisco
Antonella Cramaro
Sara Trapani
Giovanni Pracucci
Patrizia Nencini
Carlo Di Mario
Cristina Sarti
Publikationsdatum
25.08.2023
Verlag
Springer International Publishing
Erschienen in
Neurological Sciences / Ausgabe 2/2024
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-023-07023-0

Weitere Artikel der Ausgabe 2/2024

Neurological Sciences 2/2024 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Schutz der Synapsen bei Alzheimer

29.05.2024 Morbus Alzheimer Nachrichten

Mit einem Neurotrophin-Rezeptor-Modulator lässt sich möglicherweise eine bestehende Alzheimerdemenz etwas abschwächen: Erste Phase-2-Daten deuten auf einen verbesserten Synapsenschutz.

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.